ConductScience.org, home

Paper37745244

Blocking cholesterol formation and turnover improves cellular and mitochondria function in murine heart microvascular endothelial cells and cardiomyocytes.

Braczko A and 8 others. Front Physiol, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Blocking cholesterol formation and turnover improves cellular and mitochondria function in murine heart microvascular endothelial cells and cardiomyocytes. Papers, record 37745244. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37745244

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blocking cholesterol formation and turnover improves cellular and mitochondria function in murine heart microvascular endothelial cells and cardiomyocytes.
PubMed
Journal
Front Physiol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2023-09-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Braczko AAlicja
2Harasim GGabriela
3Kawecka AAda
4Walczak IIga
5Kapusta MMałgorzata
6Narajczyk MMagdalena
7Stawarska KKlaudia
8Smoleński RTRyszard T
9Kutryb-Zając BBarbara

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131766595Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications.J Clin Med2019https://conductscience.org/library/papers/31766595PubMed
224103783Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding.J Lipid Res2013https://conductscience.org/library/papers/24103783PubMed
336045572Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization.Biophys J2023https://conductscience.org/library/papers/36045572PubMed
433511728Effects of statins on mitochondrial pathways.J Cachexia Sarcopenia Muscle2021https://conductscience.org/library/papers/33511728PubMed
534676866A Modern Approach to Dyslipidemia.Endocr Rev2022https://conductscience.org/library/papers/34676866PubMed
630374710Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion.Basic Res Cardiol2018https://conductscience.org/library/papers/30374710PubMed
725911648Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction.Eur Heart J2015https://conductscience.org/library/papers/25911648PubMed
835884844CoCl2-Mimicked Endothelial Cell Hypoxia Induces Nucleotide Depletion and Functional Impairment That Is Reversed by Nucleotide Precursors.Biomedicines2022https://conductscience.org/library/papers/35884844PubMed
932674634Evolocumab, a PCSK9-Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia.J Am Heart Assoc2020https://conductscience.org/library/papers/32674634PubMed
1030761308
Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries.
Front Cardiovasc Med2018https://conductscience.org/library/papers/30761308PubMed
1119278604The role of statins in the treatment of the metabolic syndrome.Curr Hypertens Rep2009https://conductscience.org/library/papers/19278604PubMed
1220558442Endothelial mitochondria and heart disease.Cardiovasc Res2010https://conductscience.org/library/papers/20558442PubMed
1334112278RNAi of vacuolar-type H+-ATPase genes causes growth delay and molting defect in Henosepilachna vigintioctopunctata.Bull Entomol Res2021https://conductscience.org/library/papers/34112278PubMed
1430207556PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.Rev Cardiovasc Med2018https://conductscience.org/library/papers/30207556PubMed
1535048716Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis.J Am Heart Assoc2022https://conductscience.org/library/papers/35048716PubMed
1623580773Mitochondria and endothelial function.Circ Res2013https://conductscience.org/library/papers/23580773PubMed
1732586319Integrative analyses of gene expression profile reveal potential crucial roles of mitotic cell cycle and microtubule cytoskeleton in pulmonary artery hypertension.BMC Med Genomics2020https://conductscience.org/library/papers/32586319PubMed
1832329440PCSK9 promotes the secretion of pro-inflammatory cytokines by macrophages to aggravate H/R-induced cardiomyocyte injury via activating NF-κB signalling.Gen Physiol Biophys2020https://conductscience.org/library/papers/32329440PubMed
1932899944Coronary Microvascular Dysfunction.J Clin Med2020https://conductscience.org/library/papers/32899944PubMed
2029718253Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.Eur Heart J2018https://conductscience.org/library/papers/29718253PubMed

See all 64 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42181884Evolocumab early reduces IL-1β/IL-17A and improves left ventricular function in STEMI: an observational study in the real world.Front Pharmacol2026https://conductscience.org/library/papers/42181884PubMed
40648946Safety and Efficacy of Achieving Very Low LDL Cholesterol Concentrations with PCSK9 Inhibitors.J Clin Med2025https://conductscience.org/library/papers/40648946PubMed
40076547PCSK9 Enhances Cardiac Fibrogenesis via the Activation of Toll-like Receptor and NLRP3 Inflammasome Signaling.Int J Mol Sci2025https://conductscience.org/library/papers/40076547PubMed
39816559Mitochondrial cholesterol metabolism related gene model predicts prognosis and treatment response in hepatocellular carcinoma.Transl Cancer Res2024https://conductscience.org/library/papers/39816559PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GSK3B2932PubTator's text mininghttps://conductscience.org/library/genes/2932NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
NOS34846PubTator's text mininghttps://conductscience.org/library/genes/4846NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37745244

GET https://conductscience.org/api/papers/v1/37745244/references?page=2